Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Kidney Transplantation”

221 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 221 results

Post-approval studies (Phase 4)Ended earlyNCT00522548
What this trial is testing

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Who this might be right for
Transplants and Implants
University of Pennsylvania 37
Post-approval studies (Phase 4)Study completedNCT00154193
What this trial is testing

Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels

Who this might be right for
Heart and Lung Transplant
Novartis Pharmaceuticals 190
Large-scale testing (Phase 3)Study completedNCT00248313
What this trial is testing

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney Disease
Wyeth is now a wholly owned subsidiary of Pfizer 470
Testing effectiveness (Phase 2)Study completedNCT01064791
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 298
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Large-scale testing (Phase 3)Study completedNCT00378014
What this trial is testing

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 276
Not applicableUnknownNCT01382355
What this trial is testing

Prospective Donor Specific Antibody (DSA) Monitoring Protocol

Who this might be right for
Kidney TransplantKidney/Pancreas Transplant
Providence Health & Services 60
Large-scale testing (Phase 3)Study completedNCT00717678
What this trial is testing

Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationTransplantation ImmunologyHost vs Graft Reaction
Astellas Pharma Inc 73
Post-approval studies (Phase 4)Study completedNCT05152628
What this trial is testing

Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Who this might be right for
Liver TransplantationKidney Transplantation
Astellas Pharma China, Inc. 55
Testing effectiveness (Phase 2)Ended earlyNCT00282230
What this trial is testing

Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 150
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Large-scale testing (Phase 3)Study completedNCT01114529
What this trial is testing

Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 828
Large-scale testing (Phase 3)Study completedNCT00316810
What this trial is testing

Simultaneous Pancreas-kidney Transplantation With Campath Protocol

Who this might be right for
Pancreas-Kidney Transplantation
Dr. Claudia Bösmüller 30
Post-approval studies (Phase 4)Study completedNCT01802268
What this trial is testing

Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Helio Tedesco Silva Junior 320
Post-approval studies (Phase 4)Study completedNCT04033276
What this trial is testing

IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies

Who this might be right for
Renal Transplant
Seoul National University Hospital 50
Large-scale testing (Phase 3)Study completedNCT01410448
What this trial is testing

Everolimus in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 383
Large-scale testing (Phase 3)Study completedNCT00150046
What this trial is testing

Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients

Who this might be right for
Heart Transplantation
Novartis Pharmaceuticals 176
Post-approval studies (Phase 4)Study completedNCT01742624
What this trial is testing

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

Who this might be right for
de Novo Kidney Transplantation
Astellas Pharma Korea, Inc. 60
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Post-approval studies (Phase 4)Study completedNCT01950819
What this trial is testing

Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

Who this might be right for
End Stage Renal Disease (ESRD)Chronic Kidney Disease (CKD)Hemodialysis+2 more
Novartis Pharmaceuticals 2,037
Load More Results